New to the Huntington's Disease Lighthouse?
 Welcome to the HDlighthouse!
 Getting started.
 
Home \ Research \ General \ Updates
Mice Engineered Without CAG Repeats

HD Lighthouse Contributing Editor's Comment: As a major step towards treatments, HD researchers engineered mouse models of the disease by adding CAG repeats. Researchers Scott Zeitlin and Erin Clabough have now engineered a mouse without any CAG repeats in the region of the huntingtin's gene where excessive CAG repeats cause HD in people. The mice developed normally in utero unlike mice engineered to lack the huntingtin's gene altogether who die in utero. The huntingtin's protein is necessary for embryonic development, but the CAG repeats are not.

In adulthood, however, the CAG-depleted mice exhibited mild memory and learning deficits but actually performed better on the rotarod, a standard measure of motor performance, than normal mice.

The researchers suggest that the function of the CAG repeat is related to the regulation of energy within the cell. Examining cells in culture, they found that there were higher levels of ATP (adenosine triphosphate - cellular energy) present, but that the cells aged more quickly.

As RNA interference technologies improve and advance toward human clinical trials, it is important for researchers to learn all they can about the normal function of the huntingtin's protein and the role of the CAG repeats. This study shows that developing a technique to knock out the CAG regions in the normal and HD gene would not be a good therapeutic strategy.

-- Marsha L. Miller, Ph.D.
Posted to the HDL: 23 Jul 2006


Scott O. Zeitlin

Deletion of the triplet repeat encoding polyglutamine within the mouse Huntington's disease gene results in subtle behavioral/motor phenotypes in vivo and elevated levels of ATP with cellular

Erin B.D. Clabough and Scott O. Zeitlin

Huntingtin (htt), the protein encoded by the Huntington's disease (HD) gene, contains a polymorphic stretch of glutamines (polyQ) near its N-terminus. When the polyQ stretch is expanded beyond 37Q, HD results. However, the role of the normal polyQ stretch in the function of htt is still unknown. To determine the contribution of the polyQ stretch to normal htt function, we have generated mice with a precise deletion of the short CAG triplet repeat encoding 7Q in the mouse HD gene (Hdh{Delta}Q). Hdh({Delta}Q/{Delta}Q) mice are born with normal Mendelian frequency and exhibit no gross phenotypic differences in comparison to control littermates, suggesting that the polyQ stretch is not essential for htt's functions during embryonic development. Adult mice, however, commit more errors initially in the Barnes circular maze learning and memory test and perform slightly better than wild-type controls in the accelerating rotarod test for motor coordination. To determine whether these phenotypes may reflect an altered cellular physiology in the Hdh{Delta}Q mice, we characterized the growth and energy status of primary embryonic and adult Hdh({Delta}Q/{Delta}Q) fibroblasts in culture. The Hdh{Delta}Q fibroblasts exhibited elevated levels of ATP, but senesced prematurely in comparison with wild-type fibroblasts. Taken altogether, these results suggest that htt's polyQ stretch is required for modulating longevity in culture and support the hypothesis that the polyQ stretch may also modulate a htt function involved in regulating energy homeostasis.
# # #

Source: Human Molecular Genetics 2006 15(4):607-623

print this
printer friendly
version

 

Read the HDAC/HDLighthouse Forum. Post your comments
   
Related Topics
Research focusing on the formation of aggregates caused by HD
 
Research related to the role Brain Derived Neurotrophic Factor has on the pathology of HD in the brain
 
Research related HD and it's general affect on the brain
 
Learn more about the clinical trial process, trials that have been conducted and those that are underway.
 
Research related to drugs and supplements that may delay onset and slow progression of Huntington's Disease.
 
Research focusing on gene therapy.
 
Research focusing on gene transcription.
 
Research studying the genetics of Huntington's Disease
 
Research studying the Immune System and it's effect on the progression of HD
 
Research studying the brain tissue and research related to stem cells
 
Recent Updates
22 Dec 2009
Invitation to participate in a quality of life survey
Here is an opportunity to tell the medical professionals about quality of life issues.
 
6 Dec 2009
An interview with Dr. Jan Nolta
A trial of mesenchymal stem cell is planned for the end of 2010.
 
5 Dec 2009
Mesenchymal stem cells repair neurotoxin damage in an animal model
Preclinical work supports the use of mesenchymal stem cells to treat neurodegenerative disorders.
 
5 Dec 2009
The search for genetic modifiers
The search for genetic modifiers is an important part of the effort to find treatments.
 
20 Sep 2009
Axonal transport impaired in HD
Researchers have identified the mechanism by which axonal transport is impaired in neurons in HD.
 
4 Jul 2009
Rhes and the HD protein
Researchers at Johns Hopkins have discovered that a protein called rhes binds to the HD protein and causes toxicity.
 
24 Apr 2009
Acetylation of the HD protein
MSG-MIND researchers discover a new therapeutic target: increased acetylation enhances clearance of the HD ptotein from the nucleus.
 
31 Jan 2009
Impaired ERAD and ER stress
Cell model study shows that impaired ERAD and ER stress are early and specific events in polyglutamine toxicity.
 
22 Jan 2009
PGC-1 alpha gene modifies age of onset in HD
Variations in the PGC-1 alpha gene delay onset in HD, suggesting a target for treatment.
 
22 Jan 2009
PGC-1 alpha gene downregulated in HD
Researchers find a metabolic problem in the HD mice and confirm downregulation of the PGC-1 alpha gene in human patients.
 

All Updates for General
Disclaimer & Privacy Policy | Welcome | Site Feedback Marsha@HDLighthouse.org